The University of Siena PhD Course in
Genetics, Oncology and Clinical Medicine
Genetics, Oncology and Clinical Medicine
PhD Graduate

PhD Program years: 2009 - 2013
PUBLICATIONS DURING THE PHD PROGRAM
1. New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells.
Rossi A, Schenone S, Angelucci A, Cozzi M, Caracciolo V, Pentimalli F, Puca A, Pucci B, La Montagna R, Bologna M, Botta M, Giordano A.
FASEB J. 2010 Aug;24(8):2881-92.
2. Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition.
Cozzi M, Giorgi F, Marcelli E, Pentimalli F, Forte IM, Schenone S, D'urso V, De Falco G, Botta M, Giordano A, Indovina P.
Cell Cycle. 2012 Mar 1;11(5). [Epub ahead of print]
ABSTRACTS OF CONFERENCE DURING THE PHD PROGRAM
2. A selective CDK inhibitor mimicking the Spa310 as a potential anticancer agent. Esposito Luca, Conti Daniele, Cozzi Martina, Di Marzo Domenico, Forte Iris Maria, Indovina Paola, Pentimalli Francesca and Giordano Antonio(13° congresso Nazionale del GOM, Bari, 19-22 Giugno 2011)
ACTIVITY DURING THE PHD PROGRAM
TRAINING PERIOD ABROAD
-
Hosting Institution Name
Location
Period dates
-
Hosting Institution Name
Location
Period dates